Home・Список акций・Design Therapeutics Inc

Design Therapeutics Inc

Закрыт

15.05 0.74

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

15.01

Макс.

15.28

Ключевые показатели
By Trading Economics
Доход	-2.5M -20M
Прибыль на акцию	-0.32
Сотрудники	55
EBITDA	-4.5M -22M

Рекомендации
By TipRanks
Рекомендации	Активная покупка
Прогноз на 12 месяцев	+71% upside

Дивиденды
By Acuity
Следующий отчет о доходах	3 нояб. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	202M 944M
Предыдущая цена открытия	14.31
Предыдущая цена закрытия	15.05

Design Therapeutics Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

7 сент. 2026 г., 23:51 UTC

Australia's Consumer Confidence Index set for release amid mixed market sentiment and rising interest rate concerns.

7 сент. 2026 г., 23:51 UTC

Australia's Westpac Consumer Confidence Index set for release on September 8, amid cautious optimism in the stock market despite global economic uncertainties.

7 сент. 2026 г., 23:51 UTC

UK Retail Sales Growth Slows to 0.5% YoY, Falling Short of Expectations Amid Consumer Caution

7 сент. 2026 г., 23:51 UTC

U.S. Initial Jobless Claims Expected at 205,000 Amid Strong Labor Market and Anticipated Fed Rate Hikes

7 сент. 2026 г., 23:51 UTC

China's Producer Prices Index Expected to Rise 3.7% Amid Mixed Economic Signals Ahead of September Release

7 сент. 2026 г., 23:41 UTC

Japan's Q2 2026 GDP Growth Rate Expected at 0.4% Amid Optimistic Economic Sentiment and Rising Nikkei Index

7 сент. 2026 г., 23:41 UTC

Japan's Q2 2026 GDP Growth Expected at +1.1% Amid Positive Economic Trends and Optimistic Market Sentiment

7 сент. 2026 г., 23:41 UTC

Japan's Current Account Expected at JPY 2,870 Billion Amid Positive Economic Sentiment and Speculation of Interest Rate Hikes.

7 сент. 2026 г., 23:31 UTC

ECB President Lagarde's Upcoming Speech Sparks Market Anticipation for Rate Hike Amid Rising Inflation and Geopolitical Tensions.

7 сент. 2026 г., 23:21 UTC

U.S. Core Inflation Rate Expected to Rise to 2.4% YoY Amid Strong Jobs Data, Heightening Speculation on Fed Interest Rate Hikes

7 сент. 2026 г., 23:21 UTC

Core Inflation Rate Release on September 11, 2026, Expected to Influence Fed's Interest Rate Decisions Amid Rising Geopolitical Tensions and Oil Prices.

7 сент. 2026 г., 23:21 UTC

Investors Brace for CPI Release Amid Rising Inflation Concerns and Fed Rate Hike Speculation on September 11, 2026.

7 сент. 2026 г., 23:21 UTC

U.S. Inflation Rate Expected to Rise 0.4% in August Amid Concerns of Federal Reserve Interest Rate Hikes Following Strong Job Growth

7 сент. 2026 г., 23:21 UTC

U.S. CPI Report on September 11, 2026 Expected to Show Inflation Rise Amid Market Caution and Fed Rate Hike Speculation

7 сент. 2026 г., 23:21 UTC

U.S. Inflation Rate Expected to Rise 3.4% YoY, Heightening Fed Rate Hike Speculations Amid Geopolitical Tensions and Oil Price Surge

7 сент. 2026 г., 23:11 UTC

U.S. Core Producer Prices Expected to Rise 0.3% in August Amid Geopolitical Tensions and Inflation Concerns

7 сент. 2026 г., 23:01 UTC

U.S. Producer Price Inflation (PPI) MoM for August set to release on September 10, with a forecasted rise of 0.4% amid inflation concerns and potential Fed interest rate hikes due to geopolitical tensions affecting oil prices.

7 сент. 2026 г., 23:01 UTC

NZD/JPY is lower today amid broader market volatility and geopolitical tensions following U.S. military actions against Iranian tankers. The pair remains near its one-month low.

7 сент. 2026 г., 23:01 UTC

Correlated Moves

AUD/JPY is trading lower, continuing a decline since Friday's close amid geopolitical tensions affecting investor sentiment and energy supply concerns.

7 сент. 2026 г., 23:01 UTC

Correlated Moves

GBP/JPY is declining amid heightened market volatility from geopolitical tensions and U.S. military actions, continuing lower since Friday's close.

7 сент. 2026 г., 23:01 UTC

Correlated Moves

CAD/JPY is declining, continuing a downward trend since Friday's close, influenced by geopolitical tensions and market volatility. The pair trades below its 20-day moving average.

7 сент. 2026 г., 23:01 UTC

Macro News

The USD/JPY currency pair is trading lower as the yen strengthens amid global economic uncertainties and tensions in the Middle East.

7 сент. 2026 г., 23:01 UTC

Correlated Moves

The EUR/JPY is lower today amid rising geopolitical tensions and a drop in USD/JPY. The exchange rate remains below its 20-day moving average.

7 сент. 2026 г., 23:01 UTC

Correlated Moves

CHF/JPY is trading lower as geopolitical tensions influence market sentiment, following a notable decline earlier in the session. The pair remains below its 20-day moving average.

7 сент. 2026 г., 22:51 UTC

Markets Anticipate ECB Deposit Facility Rate Hike Amid Rising Inflation and Geopolitical Tensions Ahead of September 10 Meeting.

7 сент. 2026 г., 22:21 UTC

India's Inflation Rate Release on September 14, 2026, Sparks Caution Amid Geopolitical Tensions and Rising Costs.

7 сент. 2026 г., 22:11 UTC

Mexico's Inflation Rate YoY for August 2026 set to release on September 9, with a forecast of 3.30% amid rising global oil prices and geopolitical tensions.

7 сент. 2026 г., 22:11 UTC

Mexico's Inflation Rate Expected to Rise 0.25% in August Amid Global Economic Pressures and U.S. Interest Rate Concerns.

7 сент. 2026 г., 22:01 UTC

MBA 30-Year Mortgage Rate Release on September 9, Amid Rising Rates and Anticipated Fed Hikes Influenced by Inflation Concerns.

7 сент. 2026 г., 21:51 UTC

Brazil's Central Bank to Announce Interest Rate Decision Amid Global Economic Uncertainty on September 8, 2026.

Сравнение c конкурентами

Изменение цены

Design Therapeutics Inc Прогноз

Целевая цена

By TipRanks

71% рост

Прогноз на 12 месяцев

Средняя 25.89 USD 71%

Максимум 40.54 USD

Минимум 20 USD

Основано на мнении 4 аналитиков Wall Street, спрогнозировавших целевые цены для Design Therapeutics Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

4 ratings

Покупка

Удержание

Продажа

Основано на мнении 4 аналитиков, присваивавших рейтинги акциям Design Therapeutics Inc – Данные за последние 3 месяца.

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании Design Therapeutics Inc

Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.